Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPO, of the Cleveland Clinic Taussig Cancer Institute and Case Comprehensive Cancer Center, shares her advice for nurses interested in hematologic oncology. “It’s really a rewarding profession,” Dr. Faiman said, noting that it allows nurses to form supportive relationships with patients and caregivers. ...
Advertisement
Latest News
Learn how a team developed a predictive model for breast cancer using cfDNA low-pass whole genome sequencing.
The study analyzed quality-adjusted time without symptoms of disease progression or toxicity of treatment, known as Q-TWiST.
A randomized study is evaluating a nurse-led educational intervention on physical activity for patients with breast cancer.
Patients who received the vaccine within 100 days of starting an immune checkpoint inhibitor showed improved survival.
The ongoing trial is evaluating if MaaT033 can increase survival by preventing complications such as GVHD.
Narjust Florez, MD, FASCO, discusses key considerations for oncology nurses caring for these patients.
Learn what the study showed about shorter courses of post-mastectomy radiation combined with breast reconstruction.
The panel used an iterative process to create patient-facing and provider-facing consensus statements across 7 domains.
Amy Pierre, RN, BSN, ANP-BC, shares her insights on disparities in myeloma and the steps APPs can take to address them.
New research highlights the need for “early and equitable” integration of palliative care for patients with myeloma.
It's critical for oncology nurses to encourage these patients to monitor their blood pressure at home.
Renal toxicity occurs in approximately 75% of all patients who receive allogeneic stem cell transplants.
Advertisement
Advertisement
Our Contributors
Theresa Brown, RNTheresa Brown, RN, is the New York Times best-selling author of "Healing" and "The Shift."
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®, is the owner of beyond Oncology Education, LLC.
Milagros Elia, MA, APRN, ANP-BCMilagros R. Elia, MA, APRN, ANP-BC, has 25+ years of oncology experience and is a highly regarded activist.
Pamela K. Ginex, EdD, MPH, RN, OCNPamela K. Ginex, EdD, MPH, RN, OCN, is an Assistant Professor at the Stony Brook University School of Nursing.
Teresa Hagan Thomas, PhD, RNTeresa Hagan Thomas, PhD, RN, is an Assistant Professor at the University of Pittsburgh School of Nursing.
Amanda Brink, DNP, APRN, FNP-BC, AOCNPAmanda Brink, DNP, APRN, FNP-BC, AOCNP, is an oncology nurse practitioner at the MD Anderson Cancer Center.
Alicia Michaelsen, BSN, RN, BMTCN®Alicia Michaelsen, BSN, RN, BMTCN®, is a nurse with over a decade of experience.
Fatemeh Youssefi, PhD, RN, OCNFatemeh Youssefi, PhD, RN, OCN, is a nurse who has specialized in oncology for the past 20 years.
Expert Interviews
Cancer Nursing Today delivers critical news and expert insights to support oncology nurses throughout their education and careers.
Sign up to receive Cancer Nursing Today eNewsletters:
Conference Highlights
Learn how a team developed a predictive model for breast cancer using cfDNA low-pass whole genome sequencing.
The study analyzed quality-adjusted time without symptoms of disease progression or toxicity of treatment, known as Q-TWiST.
Patients who received the vaccine within 100 days of starting an immune checkpoint inhibitor showed improved survival.
The ongoing trial is evaluating if MaaT033 can increase survival by preventing complications such as GVHD.
© 2024 Mashup Media, LLC, a Formedics Property. All Rights Reserved.